News & Events > Events > Very Rare Cancer Consortium Tumor Board Meeting

Very Rare Cancer Consortium Tumor Board Meeting

Please join us for the Very Rare Cancer Consortium Tumor Board Meeting. This new initiative aims to bring cancer researchers across New York to the table to discuss compelling rare cancer cases presented by physicians and scientists from the New York Genome Center’s partner institutions. Click here to learn more about the Very Rare Cancer Consortium.

Case Conference 

Anal cancer is a rare disease with limited therapeutic options. The majority of cases are caused by HPV infection. In recent years clinicians have noted an increase in anal cancer among people with HIV in the greater NYC area. Patients with HIV have a substantial risk of aggressive high-grade anal cancer precursors and may also have worse outcomes from anal cancer. This raises questions about the role of HIV in the natural history of this poorly understood cancer and possible carcinogenic and prognostic synergies in HIV and HPV co-infection. We will hear from experts from different areas in these studies and discuss potential collaborations through the VRCC.

Any questions on this event, contact


  • Kevin Du, MD, PhD, MSCI

    Associate Professor
    Residency Program Director
    Department of Radiation Oncology
    NYU Langone Medical Center

    "Disease Overview"
  • Paz Polak, PhD

    Assistant Professor
    Department of Oncological Sciences
    Icahn School of Medicine at Mount Sinai

  • Keith Sigel, MD, PhD, MPH

    Associate Professor of Medicine
    Division of General Internal Medicine
    Division of Infectious Diseases
    Icahn School of Medicine at Mount Sinai

    "Persistent HPV16 and Multifocal Recurrent Carcinoma in Situ in a Person with HIV,  As Part of an Ethnically Diverse Cohort of Precancer Patients"(Copresented with Paz Polak, PhD)
  • David P. Horowitz, MD

    Assistant Professor of Radiation Oncology
    NewYork-Presbyterian/Columbia University Irving Medical Center

    "47-Year-Old Woman with Kidney Transplant and History of Vulvar Intraepithelial Neoplasia Who Develops Anal Cancer While On Surveillance for Gynecological Malignancy"
  • Michael Buckstein, MD, PhD

    Associate Professor and Residency Program Director
    Department of Radiation Oncology
    Icahn School of Medicine at Mount Sinai

    "A 41-Year-old Male with HIV, HSIL, and a Buschke-Lowenstein Tumor of the Anus"
  • Paul Romesser, MD

    Assistant Attending
    Early Drug Development Service, Department of Medicine
    Gastrointestinal Service, Department of Radiation Oncology
    Memorial Sloan Kettering Cancer Center

  • Salma Jabbour, MD

    Professor, Vice Chair of Clinical Research & Faculty Development
    Department of Radiation Oncology
    Rutgers Cancer Institute of New Jersey

    "57-Year-Old Woman with Synchronous Anal and Cervical Squamous Cell Carcinomas" "71-Year-Old Man Who Developed Lung Squamous Cell Carcinoma Years After Anal Squamous Cell Carcinoma" (Copresented with Paul Romesser, MD)
  • Timothy Wilkin, MD, MPH

    Professor of Medicine, Division of
    Infectious Diseases
    Assistant Dean, Clinical
    Research Compliance
    Institutional Official for
    Human Research Protections
    Weill Cornell Medicine/NewYork-Presbyterian

    "Man Living with HIV Develops Anal Cancer During Extended Observation of Anal High Grade SIL"
Decorative image color fade left Decorative image color fade right Decorative image color fade